Author: Aul, Raminder; Gates, Jessica; Draper, Adrian; Dunleavy, Anne; Ruickbie, Sachelle; Meredith, Helen; Walters, Nicola; van Zeller, Cristiano; Taylor, Victoria; Bridgett, Michael; Dunwoody, Roisin; Grubnic, Sisa; Jacob, Tersesa; Ean Ong, Yee
Title: Complications after Discharge with COVID-19 Infection and Risk Factors Associated with Development of Post-COVID Pulmonary Fibrosis Cord-id: pspko62f Document date: 2021_9_8
ID: pspko62f
Snippet: Introduction: Survivors of COVID-19 infection may develop post-covid pulmonary fibrosis (PCF) and suffer from long term multi-system complications. The magnitude and risk factors associated with these are unknown. Objectives: We investigated the prevalence and risk factors associated with PCF and other complications in patients discharged after COVID-19 infection. Methods: Patients had phone assessment 6 weeks post hospital discharge after COVID-19 infection using a set protocol. Those with sign
Document: Introduction: Survivors of COVID-19 infection may develop post-covid pulmonary fibrosis (PCF) and suffer from long term multi-system complications. The magnitude and risk factors associated with these are unknown. Objectives: We investigated the prevalence and risk factors associated with PCF and other complications in patients discharged after COVID-19 infection. Methods: Patients had phone assessment 6 weeks post hospital discharge after COVID-19 infection using a set protocol. Those with significant respiratory symptoms were investigated with a CTPA, Pulmonary Function Tests and echocardiogram. Prevalence of myalgia, fatigue, psychological symptoms and PCF was obtained. Risk factors associated with these were investigated. Results: A large number of patients had persistent (45.1%) fatigue, breathlessness (36.5%), myalgia (20.5%) and psychological symptoms (19.5%). PCF was seen in 9.5% of the patients and was associated with persistent breathlessness at 6 weeks and inpatient ventilation [adjusted OR 5.02(1.76-14.27) and 4.45(1.27-15.58)] respectively. It was more common in men and in patients with peak CRP >171.5 mg/L, peak WBC count ≥12 x 10 9/L, severe inpatient COVID-19 CXR changes and CT changes. Ventilation was also a risk factor for persisting fatigue and myalgia, the latter was also more common in those with severe cytokine storm and severe COVID-19 inpatient CXR changes. Conclusions: All the patients discharged after COVID-19 should be assessed using a set protocol by a multidisciplinary team. Patients who had severe COVID-19 infection particularly those who were intubated and who have persistent breathlessness are at risk of developing PCF. They should have a CT Chest and have respiratory follow-up.
Search related documents:
Co phrase search for related documents- additional factor and lung disease: 1, 2, 3
- additional factor and lymphocyte count: 1
- logistic regression analysis and long term complication: 1, 2
- logistic regression analysis and long term follow: 1, 2, 3, 4, 5, 6, 7, 8
- logistic regression analysis and low incidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- logistic regression analysis and low lymphocyte count: 1, 2, 3, 4, 5, 6, 7
- logistic regression analysis and low lymphocyte count wbc: 1
- logistic regression analysis and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- logistic regression analysis and lung function: 1, 2, 3, 4, 5, 6, 7
- logistic regression analysis and lv dysfunction: 1
- logistic regression analysis and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- long term complication and lung disease: 1
- long term complication and lung function: 1
- low incidence and lung disease: 1, 2, 3, 4
- low incidence and lymphocyte count: 1, 2, 3, 4, 5
- low lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- lung disease and lv dysfunction: 1
- lung disease and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- lung function and lymphocyte count: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date